Grant: Operating Grant
University of Toronto
$721,681.00
Selective Translation of HIV-1 mRNAs: Mechanism and Effect on Host Innate Immune Responses
EF 2012-13
Résumé
Upon entry into a cell, viruses have two objectives; to maximize the production of progeny virions while minimizing the activation of innate immune sensors that will limit virus replication. Recent work by our group has demonstrated that HIV-1 inhibits host cell protein synthesis, an activity essential to the activation of the innate immune response. However, we have also determined that HIV-1 uses a novel strategy to ensure efficient expression of its own proteins. Understanding how each of these processes is regulated will provide new insights to enhance the innate immune response to HIV-1 and provide tools to selectively inhibit HIV-1 gene expression.
Programme
Operating Grant
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
281409
Name
Cochrane Alan W
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Virology & Viral Pathogenesis
Projecttitle
Selective Translation of HIV-1 mRNAs: Mechanism and Effect on Host Innate Immune Responses
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$721,681
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Hiv; Innate Immunity; Rna Processing
Abstract
Upon entry into a cell, viruses have two objectives; to maximize the production of progeny virions while minimizing the activation of innate immune sensors that will limit virus replication. Recent work by our group has demonstrated that HIV-1 inhibits host cell protein synthesis, an activity essential to the activation of the innate immune response. However, we have also determined that HIV-1 uses a novel strategy to ensure efficient expression of its own proteins. Understanding how each of these processes is regulated will provide new insights to enhance the innate immune response to HIV-1 and provide tools to selectively inhibit HIV-1 gene expression.
Competitiondate
201303
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Cochrane, Alan W
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $721,681~ $0~